Logo image of SRRA

Sierra Oncology Inc (SRRA) Stock Earnings & Estimates

NASDAQ:SRRA - US82640U4040 - Common Stock

54.99
+0.02 (+0.04%)
Last: 6/30/2022, 8:00:01 PM
54.99
0 (0%)
After Hours: 6/30/2022, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
SRRA revenue by date.SRRA revenue by date.
300K
-100.00%
29.269M173.586M
493.07%
425.456M
145.10%
1.064B
150.00%
EBITDA
YoY % growth
SRRA ebitda by date.SRRA ebitda by date.
-55.31M
-30.57%
-66.91M
-20.97%
-64.7M
3.30%
N/A
-45.72%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
SRRA ebit by date.SRRA ebit by date.
-55.42M
-30.03%
-66.99M
-20.88%
-64.94M
3.06%
-93.539M
-45.64%
-100.978M
-6.76%
-89.993M
10.88%
2.825M
103.14%
1.278M
-54.77%
589.465K
-53.87%
Operating Margin
SRRA operating margin by date.SRRA operating margin by date.
N/AN/A-21,646.67%N/AN/A-307.47%1.63%0.30%0.06%
EPS
YoY % growth
SRRA eps by date.SRRA eps by date.
-30.00
11.76%
-29.48
1.73%
-5.91
79.95%
-7.22
-20.98%
-4.89
31.62%
-3.94
19.37%
0.02
100.60%
0.01
-60.18%
0.00
-59.38%

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth
-0.97
41.98%
-1.12
46.81%
-1.30
22.13%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
-21.447M
-4.26%
-25.045M
12.43%
-28.494M
-11.35%

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth
-1.33
22.22%
-1.05-0.28-27.00%
Q4 2021
Q2Q % growth
-1.67
-2.45%
-1.57-0.10-6.45%
Q3 2021
Q2Q % growth
-2.10
-51.08%
-1.82-0.28-15.70%
Q2 2021
Q2Q % growth
-1.67
-5.70%
-1.65-0.02-1.38%
Q1 2021
Q2Q % growth
-1.71
-30.53%
-1.64-0.07-4.45%
Q4 2020
Q2Q % growth
-1.63
79.31%
-1.55-0.08-5.31%
Q3 2020
Q2Q % growth
-1.39
79.56%
-1.680.2917.03%
Q2 2020
Q2Q % growth
-1.58
80.25%
-1.660.084.75%
Q1 2020
Q2Q % growth
-1.31
80.74%
-2.791.4853.13%
Q4 2019
Q2Q % growth
-7.88 -3.23-4.65-144.09%
Q3 2019
Q2Q % growth
-6.80 -8.571.7720.63%
Q2 2019
Q2Q % growth
-8.00 -8.020.020.30%
Q1 2019
Q2Q % growth
-6.80 -8.431.6319.36%
SRRA Yearly EPS VS EstimatesSRRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -100 -200 -300 -400
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth

-100.00%
%
Q3 2021
Q2Q % growth

-100.00%
%
SRRA Yearly Revenue VS EstimatesSRRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A